Literature DB >> 8141396

Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats.

A Terao1, M Oikawa, M Saito.   

Abstract

To examine the effects of brain cytokines on the sympathetic nervous system, norepinephrine (NE) turnover in peripheral organs (spleen, lung, diaphragm, pancreas, heart, liver, kidney, and interscapular brown adipose tissue) was assessed after intraperitoneal or intracerbroventricular administrations of human recombinant interleukin (IL)-1 beta and IL-6 in rats. An intraperitoneal injection of IL-1 (1 microgram/rat) accelerated NE turnover in the spleen, lung, diaphragm, and pancreas without appreciable effects in other organs examined. When IL-1 was injected intracerebroventricularly at much lower doses (1-100 ng/rat), a dose-dependent increase in NE turnover was observed in the spleen, lung, diaphragm, and pancreas. IL-6 did not affect NE turnover in every organ examined, even when it was given at much higher doses, 100 micrograms/rat and 100 ng/rat for intraperitoneal and intracerebroventricular injections, respectively. In contrast to tissue NE turnover, plasma corticosterone level was increased after the administration of IL-6 as well as IL-1, regardless of the site of administration. These results suggest that central IL-1, but not IL-6, increases sympathetic nerve activity in some specific organs, whereas both cytokines are effective for adrenocortical activation. A possible role of the sympathetic nervous system in physiological and immune responses to central IL-1 was discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141396     DOI: 10.1152/ajpregu.1994.266.2.R400

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Effect of interferon-alpha on DOI-induced wet-dog shakes in rats.

Authors:  A Kugaya; A Kagaya; Y Uchitomi; N Yokota; S Yamawaki
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 2.  Neurogenic factors in renal hypertension.

Authors:  Vito M Campese; Ewa Krol
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 3.  Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis.

Authors:  N Barkhudaryan; A J Dunn
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

4.  Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.

Authors:  P Härle; R H Straub; R Wiest; A Mayer; J Schölmerich; F Atzeni; M Carrabba; M Cutolo; P Sarzi-Puttini
Journal:  Ann Rheum Dis       Date:  2005-06-07       Impact factor: 19.103

5.  Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain.

Authors:  A Terao; H Matsumura; M Saito
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

6.  Increased fat:carbohydrate oxidation ratio in Il1ra (-/-) mice on a high-fat diet is associated with increased sympathetic tone.

Authors:  D Chida; O Hashimoto; M Kuwahara; H Sagara; T Osaka; H Tsubone; Y Iwakura
Journal:  Diabetologia       Date:  2008-07-02       Impact factor: 10.122

7.  Central nervous system administration of interleukin-6 produces splenic sympathoexcitation.

Authors:  Bryan G Helwig; Robin A Craig; Richard J Fels; Frank Blecha; Michael J Kenney
Journal:  Auton Neurosci       Date:  2008-06-10       Impact factor: 3.145

Review 8.  Autonomic nervous system and immune system interactions.

Authors:  M J Kenney; C K Ganta
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

9.  Sympathetic renal innervation and resistant hypertension.

Authors:  Vito M Campese; Elaine Ku; Jeanie Park
Journal:  Int J Hypertens       Date:  2011-01-20       Impact factor: 2.420

10.  Altered sympathetic-to-immune cell signaling via β₂-adrenergic receptors in adjuvant arthritis.

Authors:  Dianne Lorton; Denise L Bellinger; Jill A Schaller; Eric Shewmaker; Tracy Osredkar; Cheri Lubahn
Journal:  Clin Dev Immunol       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.